Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials

by Nelson, Mark, Hill, Andrew, van Delft, Yvon, Moecklinghoff, Christiane
Published 2014

Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial

by Geretti, Anna Maria, Moeketsi, Mathe, Demasi, Ralph, van Delft, Yvon, Mohammed, Perry
Published 2015

No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogue...

by Solomon, Ajantha, Tennakoon, Surekha, Leeansyah, Edwin, Arribas, Jose, Hill, Andrew, Van Delft, Yvon, Moecklinghoff, Christiane, Lewin, Sharon R.
Published 2014

The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL

by Antinori, Andrea, Arribas, Jose, Fehr, Jan, Girard, Pierre-Marie, Horban, Andrzej, Hill, Andrew, van Delft, Yvon, Moecklinghoff, Christiane, Hill, Andrew
Published 2014